Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Luis J. Nannini, N. Brandan & O. M. Fernández. (2023) Bronchodilator responsiveness testing with inhaled budesonide/formoterol in asthma. Journal of Asthma 60:11, pages 1997-2001.
Read now
Read now
Luis J. Nannini, Nadia Brandan & Octavio M. Fernandez. (2023) Achieving zero asthma-related hospitalisations in the world´s first SABA-free Asthma Center in Argentina. Journal of Asthma 60:6, pages 1057-1060.
Read now
Read now
L. J. Nannini, S. Luhning, R. A. Rojas, J. M. Antunez, J. L. Miguel Reyes, C. Cano Salas & R. Stelmach. (2021) Position statement: asthma in Latin America. IS short-acting beta-2 agonist helping or compromising asthma management?. Journal of Asthma 58:8, pages 991-994.
Read now
Read now
Luis Javier Nannini. (2021) Is It Time to Leave Behind the Concept of Asthma Control and Severity Steps?. Journal of Asthma 58:3, pages 281-283.
Read now
Read now
Articles from other publishers (3)
Vahideh Abbasnia, Mohsen Foadoddini, Delaram Eslimi Esfahani, Mohammad Reza Khazdair & Shahrbanoo Oryan. (2024) Rosmarinic acid improves tracheal smooth muscle responsiveness and lung pathological changes in ovalbumin-sensitized rats. Asian Pacific Journal of Tropical Biomedicine 14:3, pages 100-105.
Crossref
Crossref
Giovanna Elisiana Carpagnano, Andrea Portacci, Santi Nolasco, Aikaterini Detoraki, Alessandro Vatrella, Cecilia Calabrese, Corrado Pelaia, Francesca Montagnolo, Giulia Scioscia, Giuseppe Valenti, Maria D’Amato, Maria Filomena Caiaffa, Massimo Triggiani, Nicola Scichilone & Claudia Crimi. (2024) Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission. Frontiers in Immunology 15.
Crossref
Crossref
A. Yu. Kraposhina, E. A. Sobko, I. V. Demko, A. B. Katser, O. V. Kazmerchuk, Yu. I. Abramov & S. V. Chubarova. (2022) New options for severe asthma. Meditsinskiy sovet = Medical Council 16:18, pages 20-28.
Crossref
Crossref